Показания к применению
для лечения хронического лимфоцитарного лейкоза и мантийноклеточной лимфомы
Действующее вещество:
IBRUTINIB
Описание препарата на английском
The treatment of adult patients with MCL (Mantle Cell Lymphoma) who have received at least one prior therapy.Imbruvica is indicated for the treatment of adult patients with Chronic Lymphocytic Leukemia (CLL) who have received at least one prior therapy.The treatment of adult patients with Chronic Lymphocytic Leukemia (CLL) with 17p deletion.Imbruvica is indicated for the treatment of adult patients with Waldenstr?m’s macroglobulinemia
| Характеристики | |
| По рецепту | по рецепту |
| Срок годности | 24 мес. |
| Форма употребления | CAPSULES |
Ссылка на сайт МинЗдрава Израиля: http://www.old.health.gov.il/units/pharmacy/trufot/PerutTrufa.asp?Reg_Number=151 98 34062 00&safa=e
Имбрувика